According to MannKind Corp's latest financial reports the company's total assets are $0.47 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.47 B | 60.93% |
2022-12-31 | $0.29 B | -8.06% |
2021-12-31 | $0.32 B | 195.71% |
2020-12-31 | $0.10 B | 15.88% |
2019-12-31 | $93.72 M | -12.98% |
2018-12-31 | $0.10 B | 27.35% |
2017-12-31 | $84.57 M | -21% |
2016-12-31 | $0.10 B | -15.31% |
2015-12-31 | $0.12 B | -67.95% |
2014-12-31 | $0.39 B | 52.5% |
2013-12-31 | $0.25 B | 2.92% |
2012-12-31 | $0.25 B | 25.94% |
2011-12-31 | $0.19 B | -28.03% |
2010-12-31 | $0.27 B | 12.07% |
2009-12-31 | $0.24 B | -12.41% |
2008-12-31 | $0.28 B | -48.02% |
2007-12-31 | $0.54 B | 0.69% |
2006-12-31 | $0.53 B | 136.34% |
2005-12-31 | $0.22 B | 39.69% |
2004-12-31 | $0.16 B | 29.88% |
2003-12-31 | $0.12 B | 20.14% |
2002-12-31 | $0.10 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $226.50 B | 47,564.55% | ๐บ๐ธ USA |
Novo Nordisk NVO | $46.57 B | 9,701.43% | ๐ฉ๐ฐ Denmark |
Eli Lilly LLY | $64.00 B | 13,369.40% | ๐บ๐ธ USA |
Merck MRK | $106.67 B | 22,348.54% | ๐บ๐ธ USA |
Halozyme Therapeutics HALO | $1.73 B | 264.75% | ๐บ๐ธ USA |
Nektar Therapeutics
NKTR | $0.39 B | -16.24% | ๐บ๐ธ USA |